Vir Biotechnology, Inc. (VIR)
NASDAQ: VIR · Real-Time Price · USD
10.28
-0.36 (-3.38%)
At close: Apr 28, 2026, 4:00 PM EDT
10.27
-0.01 (-0.10%)
After-hours: Apr 28, 2026, 7:54 PM EDT
Vir Biotechnology Employees
Vir Biotechnology had 367 employees as of December 31, 2025. The number of employees decreased by 41 or -10.05% compared to the previous year.
Employees
367
Change (1Y)
-41
Growth (1Y)
-10.05%
Revenue / Employee
$186,801
Profits / Employee
-$1,193,425
Market Cap
1.66B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Intellia Therapeutics | 377 |
| Nurix Therapeutics | 317 |
| Nuvation Bio | 298 |
| Innoviva | 159 |
| Monte Rosa Therapeutics | 150 |
| AnaptysBio | 104 |
| Nanobiotix | 103 |
| AtaiBeckley | 99 |
VIR News
- 5 days ago - Vir Biotechnology to Host Conference Call for First Quarter 2026 Financial Results - Business Wire
- 12 days ago - Vir Biotechnology Announces Closing of Global Strategic Collaboration with Astellas for the Treatment of Prostate Cancer - Business Wire
- 15 days ago - Vir Biotechnology Announces First Patient Dosed in Phase 1 Dose-expansion Cohorts Evaluating PSMA-targeted, PRO-XTEN® Dual-masked T-cell Engager VIR-5500 in Patients with Metastatic Prostate Cancer - Business Wire
- 7 weeks ago - Vir Biotechnology Transcript: Leerink Global Healthcare Conference 2026 - Transcripts
- 2 months ago - Vir Biotechnology Transcript: TD Cowen 46th Annual Health Care Conference - Transcripts
- 2 months ago - Vir Biotechnology to Participate in Upcoming Investor Conferences - Business Wire
- 2 months ago - Vir Biotechnology Announces Pricing of Public Offering of Common Stock - Business Wire
- 2 months ago - Vir Biotechnology Announces Proposed Public Offering of Common Stock - Business Wire